Kate Therapeutics is a patient-focused biotechnology company developing AAV-based gene therapies to treat genetically defined muscle and heart diseases. Kate Therapeutics applies novel technology platforms that directly address key limitations of current gene therapies, including tissue-specific delivery, liver detargeting, and gene regulation.

Kate Therapeutics

Kate Therapeutics (KateTx) is a patient-focused biotechnology company developing adeno-associated virus (AAV)-based gene therapies to treat genetically defined muscle and heart diseases. The company is applying novel technology platforms that directly address the key limitations of current gene therapies, including tissue-specific delivery and gene regulation. These breakthroughs have the potential to improve the efficacy and safety of gene therapies and enable the pursuit of a broader set of targets that are otherwise difficult to drug with current technologies.

KATE

COM:KATETHERAPEUTICS

Kate Therapeutics

locale

market

industry

website

linkedin

peer of

investor of

Metrics